Amalgamated Bank Bio Rad Laboratories, Inc. Transaction History

Amalgamated Bank

  • $12.1 Billion
  • Q3 2024

A detailed history of Amalgamated Bank transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 9,033 shares of BIO stock, worth $3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
9,033
Previous 4,112 119.67%
Holding current value
$3 Million
Previous $1.12 Million 169.1%
% of portfolio
0.02%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
BUY
$263.97 - $344.64 $1.3 Million - $1.7 Million
4,921 Added 119.67%
9,033 $3.02 Million
Q2 2024

Aug 12, 2024
SELL
$268.26 - $339.48 $70,284 - $88,943
-262 Reduced 5.99%
4,112 $1.12 Million
Q1 2024

Apr 23, 2024
SELL
$304.11 - $351.99 $204,057 - $236,185
-671 Reduced 13.3%
4,374 $1.51 Million
Q4 2023

Feb 06, 2024
SELL
$269.37 - $365.04 $64,648 - $87,609
-240 Reduced 4.54%
5,045 $1.63 Million
Q3 2023

Nov 08, 2023
SELL
$350.25 - $422.63 $129,592 - $156,373
-370 Reduced 6.54%
5,285 $1.89 Million
Q2 2023

Aug 11, 2023
SELL
$359.49 - $486.4 $17,255 - $23,347
-48 Reduced 0.84%
5,655 $2.14 Million
Q1 2023

May 02, 2023
SELL
$418.69 - $503.0 $914,837 - $1.1 Million
-2,185 Reduced 27.7%
5,703 $2.73 Million
Q4 2022

Feb 10, 2023
BUY
$351.71 - $456.01 $857,468 - $1.11 Million
2,438 Added 44.73%
7,888 $3.32 Million
Q3 2022

Nov 09, 2022
SELL
$412.59 - $563.26 $118,825 - $162,218
-288 Reduced 5.02%
5,450 $2.27 Million
Q2 2022

Aug 15, 2022
SELL
$463.67 - $597.16 $16,692 - $21,497
-36 Reduced 0.62%
5,738 $2.84 Million
Q1 2022

Jun 30, 2022
SELL
$524.57 - $735.42 $194,615 - $272,840
-371 Reduced 6.04%
5,774 $3.25 Million
Q4 2021

Feb 15, 2022
BUY
$708.84 - $794.68 $46,783 - $52,448
66 Added 1.09%
6,145 $4.64 Million
Q3 2021

Oct 29, 2021
SELL
$657.71 - $825.77 $142,723 - $179,192
-217 Reduced 3.45%
6,079 $4.54 Million
Q2 2021

Aug 16, 2021
BUY
$576.64 - $649.04 $2.96 Million - $3.33 Million
5,137 Added 443.23%
6,296 $4.06 Million
Q1 2021

May 13, 2021
SELL
$547.01 - $662.35 $23,521 - $28,481
-43 Reduced 3.58%
1,159 $662,000
Q4 2020

Feb 12, 2021
SELL
$510.68 - $643.45 $1,021 - $1,286
-2 Reduced 0.17%
1,202 $700,000
Q3 2020

Oct 30, 2020
SELL
$454.43 - $535.6 $9,543 - $11,247
-21 Reduced 1.71%
1,204 $621,000
Q2 2020

Aug 10, 2020
SELL
$334.87 - $493.06 $1.2 Million - $1.76 Million
-3,571 Reduced 74.46%
1,225 $553,000
Q1 2020

May 13, 2020
SELL
$320.01 - $409.07 $30,720 - $39,270
-96 Reduced 1.96%
4,796 $1.68 Million
Q4 2019

Feb 13, 2020
BUY
$319.73 - $374.2 $163,062 - $190,842
510 Added 11.64%
4,892 $1.81 Million
Q3 2019

Nov 13, 2019
SELL
$304.55 - $345.24 $19,186 - $21,750
-63 Reduced 1.42%
4,382 $1.46 Million
Q2 2019

Aug 14, 2019
BUY
$286.93 - $312.59 $60,542 - $65,956
211 Added 4.98%
4,445 $1.39 Million
Q1 2019

May 15, 2019
BUY
$224.3 - $317.41 $16,149 - $22,853
72 Added 1.73%
4,234 $1.29 Million
Q4 2018

Feb 15, 2019
SELL
$220.1 - $309.0 $12,325 - $17,304
-56 Reduced 1.33%
4,162 $966,000
Q3 2018

Nov 14, 2018
SELL
$289.28 - $326.15 $1,735 - $1,956
-6 Reduced 0.14%
4,218 $1.32 Million
Q2 2018

Jul 18, 2018
BUY
$244.1 - $303.88 $7,567 - $9,420
31 Added 0.74%
4,224 $1.22 Million
Q1 2018

May 22, 2018
SELL
$233.97 - $274.11 $7,954 - $9,319
-34 Reduced 0.8%
4,193 $1.05 Million
Q4 2017

Feb 13, 2018
BUY
$216.94 - $271.3 $51,631 - $64,569
238 Added 5.97%
4,227 $1.01 Million
Q3 2017

Nov 09, 2017
BUY
$212.27 - $242.28 $846,745 - $966,454
3,989
3,989 $886,000

Others Institutions Holding BIO

# of Institutions
457
Shares Held
18.2M
Call Options Held
19.5K
Put Options Held
13.9K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.19B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email